Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent

por El-Saadi, Madison Wynne, Williams-Hart, Tara, Salvatore, Brian A, Mahdavian, Elahe
Publicado 2015

TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors

por Carroll, Natalie, Youngblood, Reneau, Smith, Alena, Dragoi, Ana-Maria, Salvatore, Brian A., Mahdavian, Elahe
Publicado 2022

Caspase-dependent signaling underlies glioblastoma cell death in response to the fungal metabolite, fusarochromanone

por MAHDAVIAN, ELAHE, MARSHALL, MONIQUE, MARTIN, PATRICK M., CAGLE, PATRICE, SALVATORE, BRIAN A., QUICK, QUINCY A.
Publicado 2014

Binding Studies of AICAR and Human Serum Albumin by Spectroscopic, Theoretical, and Computational Methodologies

por Hashempour, Shokoufeh, Shahabadi, Nahid, Adewoye, Aishat, Murphy, Brennen, Rouse, Camaray, Salvatore, Brian A., Stratton, Christopher, Mahdavian, Elahe
Publicado 2020

Fusarochromanone Induces G(1) Cell Cycle Arrest and Apoptosis in COS7 and HEK293 Cells

por Gu, Ying, Chen, Xin, Shang, Chaowei, Singh, Karnika, Barzegar, Mansoureh, Mahdavian, Elahe, Salvatore, Brian A., Jiang, Shanxiang, Huang, Shile
Publicado 2014

Fusarochromanone-induced reactive oxygen species results in activation of JNK cascade and cell death by inhibiting protein phosphatases 2A and 5

por Gu, Ying, Barzegar, Mansoureh, Chen, Xin, Wu, Yang, Shang, Chaowei, Mahdavian, Elahe, Salvatore, Brian A., Jiang, Shanxiang, Huang, Shile
Publicado 2015

Biological activities of fusarochromanone: a potent anti-cancer agent

por Mahdavian, Elahe, Palyok, Phillip, Adelmund, Steven, Williams-Hart, Tara, Furmanski, Brian D, Kim, Yoon-Jee, Gu, Ying, Barzegar, Mansoureh, Wu, Yang, Bhinge, Kaustubh N, Kolluru, Gopi K, Quick, Quincy, Liu, Yong-Yu, Kevil, Christopher G, Salvatore, Brian A, Huang, Shile, Clifford, John L
Publicado 2014